BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 31387105)

  • 1. The Clinicopathological Characteristics of Henoch-Schönlein Purpura Nephritis with Presentation of Nephrotic Syndrome.
    Tan J; Tang Y; Xu Y; Yan S; Xu Y; Tan L; Zhong Z; Tarun P; Qin W
    Kidney Blood Press Res; 2019; 44(4):754-764. PubMed ID: 31387105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
    Yu M; Song X; Guo J; Feng Q; Tian J
    Eur J Pediatr; 2024 Jul; 183(7):3117-3128. PubMed ID: 38668796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Prognosis and Related Risk Factors for Henoch-Schönlein Purpura Nephritis: A Chinese Adult Patient Cohort.
    Huang X; Wu X; Le W; Hao Y; Wu J; Zeng C; Liu Z; Tang Z
    Sci Rep; 2018 Apr; 8(1):5585. PubMed ID: 29615640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary proteomics of Henoch-Schönlein purpura nephritis in children using liquid chromatography-tandem mass spectrometry.
    Fang X; Wu H; Lu M; Cao Y; Wang R; Wang M; Gao C; Xia Z
    Clin Proteomics; 2020; 17():10. PubMed ID: 32190014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences of clinicopathological characteristics and outcomes of IgA nephropathy patients with and without nephrotic syndrome.
    Huang N; Li J; Ai Z; Guo L; Chen W; Liu Q
    Int Urol Nephrol; 2024 Apr; ():. PubMed ID: 38564075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of tripterygium wilfordii poly-glycosides on glomerulonephritis: a systematic review and meta-analysis.
    Yan X; Shi J; Zhang Y; Liu J; Lin X; Yu C; Li X
    Front Pharmacol; 2024; 15():1339153. PubMed ID: 38841368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity is associated with Henoch-Schönlein Purpura Nephritis and development of end-stage renal disease in children.
    Zheng X; Chen Q; Chen L
    Ren Fail; 2019 Nov; 41(1):1016-1020. PubMed ID: 31735105
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis.
    Shi D; Chan H; Yang X; Zhang G; Yang H; Wang M; Li Q
    PLoS One; 2019; 14(10):e0223218. PubMed ID: 31574112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Henoch-Schönlein Purpura in Children: An Updated Review.
    Leung AKC; Barankin B; Leong KF
    Curr Pediatr Rev; 2020; 16(4):265-276. PubMed ID: 32384035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
    Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
    BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemotologic Indices for Predicting Internal Organ Involvement in Henoch-Schönlein Purpura (IgA vasculitis).
    Özdemir ZC; Çetin N; Kar YD; Öcal HO; Bilgin M; Bör Ö
    J Pediatr Hematol Oncol; 2020 Jan; 42(1):e46-e49. PubMed ID: 31851146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA vasculitis with nephritis in children.
    Dyga K; Szczepańska M
    Adv Clin Exp Med; 2020 Apr; 29(4):513-519. PubMed ID: 32356414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
    PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Henoch-Schonlein purpura in pediatrics: Ten years of experience at a moderate risk office of a general hospital.
    Gómez S; Pérez M; Pellegrini M; Isern E; Quintana C; Artacho P; Bertolini M; Pomerantz B; Gadda N
    Arch Argent Pediatr; 2020 Feb; 118(1):31-37. PubMed ID: 31984693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review.
    Reamy BV; Servey JT; Williams PM
    Am Fam Physician; 2020 Aug; 102(4):229-233. PubMed ID: 32803924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.
    Delbet JD; Geslain G; Auger M; Hogan J; Salomon R; Peuchmaur M; Deschênes G; Buob D; Parmentier C; Ulinski T
    Pediatr Nephrol; 2020 Feb; 35(2):313-320. PubMed ID: 31696358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for renal involvement in Henoch-Schönlein purpura.
    Kim WK; Kim CJ; Yang EM
    J Pediatr (Rio J); 2021; 97(6):646-650. PubMed ID: 33722533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dexamethasone and gamma globulin combined with prednisone on the therapeutic effect and immune function of Henoch-Schonlein purpura nephritis in children.
    Chen L; Wang X; Yin L; Ma K; Liu X
    J Clin Lab Anal; 2021 Jan; 35(1):e23580. PubMed ID: 33174652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy.
    Maritati F; Canzian A; Fenaroli P; Vaglio A
    Presse Med; 2020 Oct; 49(3):104035. PubMed ID: 32645417
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.